[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-30954":3,"doc-seo-30954":21},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":4,"is_deleted":4,"is_public":19,"is_downloadable":19,"audit_status":19,"update_tm":20},30954,1374391974585,"Genevieve","https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",7,"Healthcare","Educational Objective: Benign Prostatic Hyperplasia and Medication Effects","Benign prostatic hyperplasia causes bladder outlet obstruction manifested by weak urinary stream, intermittency, incomplete emptying, hesitancy, straining to void, and obstructive voiding symptoms. Androgen-mediated prostate enlargement contributes to static obstruction, while prostate smooth muscle contraction through α-adrenergic receptors contributes to dynamic obstruction. Finasteride improves symptoms by inhibiting 5-α-reductase, limiting conversion of testosterone to dihydrotestosterone and slowing further prostate growth. α-adrenergic blockers relax smooth muscle in the bladder neck and prostate to reduce urinary obstruction.","cbCaiq4skyVpSo8K","https://ap.wps.com/l/cbCaiq4skyVpSo8K","pdf",60616112,1,1778363953,{"code":4,"msg":22,"data":23},"ok",{"site_id":24,"language":25,"slug":26,"title":13,"keywords":27,"description":14,"schema_data":28,"social_meta":62,"head_meta":64,"extra_data":66,"updated_unix":20},105,"en","educational-objective-benign-prostatic-hyperplasia-and-medication-effects","",{"@graph":29,"@context":61},[30,47],{"@type":31,"itemListElement":32},"BreadcrumbList",[33,37,41,44],{"item":34,"name":35,"@type":36,"position":19},"https://docshare.wps.com","Home","ListItem",{"item":38,"name":39,"@type":36,"position":40},"https://docshare.wps.com/document/","Document",2,{"item":42,"name":12,"@type":36,"position":43},"https://docshare.wps.com/document/healthcare/",3,{"item":45,"name":13,"@type":36,"position":46},"https://docshare.wps.com/document/educational-objective-benign-prostatic-hyperplasia-and-medication-effects/30954",4,{"url":45,"name":13,"@type":48,"author":49,"headline":13,"publisher":51,"fileFormat":54,"description":14,"dateModified":55,"datePublished":55,"encodingFormat":54,"isAccessibleForFree":56,"interactionStatistic":57},"DigitalDocument",{"name":9,"@type":50},"Person",{"url":34,"name":52,"@type":53},"DocShare","Organization","application/pdf","2026-05-09",true,{"@type":58,"interactionType":59,"userInteractionCount":4},"InteractionCounter",{"@type":60},"ViewAction","https://schema.org",{"og:url":45,"og:type":63,"og:title":13,"og:site_name":52,"og:description":14},"article",{"robots":65,"canonical":45},"index,follow",{"doc_id":7,"site_id":24}]